MedPath

VIPIDIA 12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

VIPIDIA 12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Commercialized
Register Number

113844012

Prescription Type

Medicamento Sujeto A Prescripción Médica

Authorization Date

Jan 15, 2014

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number113844012
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

ALOGLIPTINAActive
Quantity: 12,5 mg
Name: ALOGLIPTINA

ATC CLASSIFICATION (3)

A10B
A10BH
A10BH04

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.